Health in Georgia

1,138 indicators covering health for Georgia.

IndicatorLatest Year10-yr change Rank
Hospital beds 40.45 2023 up 32.8% 37th
Treatment success rate for patients treated for MDR-TB 81.0% 2022 up 68.8% 46th
New leprosy case detection rate per 1 000 000 population 0 2024 β€” 124th
Treatment success rate: HIV-positive TB cases 71 2023 up 4.4% 85th
Bladder cancer death rate 1.88 2023 down 6.4% 52nd
Cancer death rates by type who db 1.88 2023 down 6.4% 52nd
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 85.0% 2025 β€” 100th
International Health Regulations core capacity scores, SPAR version 40 2025 β€” 112th
Leprosy registered prevalence rate per 1 000 000 population 0 2024 β€” 121st
Leprosy - Number of new leprosy cases among children 0 2024 β€” 69th
Leprosy - Number of cases registered for treatment 0 2024 β€” 121st
New leprosy child case detection rate (less than 15 years of age) per 0 2024 β€” 69th
Ipv1 number unvaccinated 1,857 2023 down 96.5% 130th
Contraceptive prevalence, any method 39.3% 2018 up 21.9% 83rd
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 β€” 3rd
Age-standardized prevalence of current tobacco use among persons aged 33.0% 2024 down 1.8% 18th
Liver cancer death rate 5.3 2023 up 36.7% 20th
Number of female leprosy new cases 0 2024 β€” 102nd
Estimated number of malaria deaths 0 2024 β€” 66th
Estimated number of malaria cases 0 2024 β€” 82nd
National smoking ban: NUMBER OF PLACES SMOKE-FREE 7 2022 up 133.3% 73rd
Contraceptive prevalence, any modern method 31.2% 2018 up 35.7% 80th
Number of prevalent tuberculosis cases 5,900 2014 down 60.7% 96th
Estimated malaria incidence 0 2024 β€” 82nd
Estimated malaria mortality rate 0 2024 β€” 66th
Number of new G2D leprosy cases 0 2024 β€” 86th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 β€” 86th
Public health expenditure share gdp 2.23 2023 up 126.1% 57th
Proportion of total government spending on essential services, health 7.1% 2024 down 4.0% 88th
Pancreatic cancer death rate 2.89 2023 up 34.2% 85th
Brain and nervous system cancer death rate 3.06 2023 down 6.2% 56th
Inflation-adjusted prices for most sold brand of cigarettes: Prices 6.21 2022 up 90.5% 93rd
Taxes as a % of price: total tax 74.5% 2022 up 59.1% 43rd
Taxes as a % of price: value added tax 15.2% 2022 unchanged 50th
Taxes as a % of price: ad valorem excise 30.0% 2022 β€” 40th
Taxes as a % of price: specific excise 27.4% 2022 down 13.2% 82nd
Taxes as a % of price: import duties 1.8% 2022 β€” 29th
Taxes as a % of price: other taxes 0.0% 2022 β€” 56th
Inflation-adjusted prices for most sold brand of cigarettes: Price in 6.2 2022 up 103.3% 142nd
Physical activity policies for activie societies 10 2023 down 50.0% 111th
Physical activity policies focused on active systems 10 2023 down 50.0% 99th
Midwifery personnel 348 2024 down 42.7% 108th
Number of deaths from malaria who 0 2024 β€” 66th
Death rate from malaria 0 2024 β€” 66th
Incidence of malaria 0 2024 β€” 79th
Share of one year olds who received the final dose of pneumococcal vac 82 2024 up 412.5% 96th
Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 82 2024 up 412.5% 96th
Death rate from poisonings 1.1 2021 up 120.0% 45th
Mortality rate attributed to cardiovascular disease, cancer, diabetes 22.1 % 2021 down 21.6% 52nd
Mortality rate attributed to unintentional poisonings, by sex 1.1 per 100,000 people 2021 up 120.0% 42nd
Suicide mortality rate, by sex 5.1 per 100,000 people 2021 up 59.4% 112th
Rotavirus number unvaccinated 12,072 2023 down 62.8% 66th
Share of deaths registered 92.47 2019 β€” 91st
Affordability - percentage of GDP per capita required to purchase 3.14 2022 up 20.3% 100th
Health expenditure and financing per capita 1,389 2023 up 45.6% 50th
Road deaths over the long term 430 2022 down 28.9% 39th
Japanese encephalitis - number of reported cases 0 2020 β€” 19th
Malaria cases reported 0 2024 β€” 81st
Deaths and missing persons due to natural disasters 1.16 2023 down 25.2% 52nd
Mean systolic blood pressure 133.2 2009 up 0.1% 7th